Table 2 Current application and future development of robotic surgery in head and neck non-malignant diseases

From: Robotic surgical systems in maxillofacial surgery: a review

Patients

Superiority

Limitations

Future development

Lip and palate cleft110111

Low damage to the vascularization and related innervation of surrounding muscles, quick function recovery

Long surgical duration

More high-quality clinical investigation

Maxillofacail fracture

Insufficient data

Insufficient data

Specific design of related robotic surgical system

Craniofacial asymmetry114115

Insufficient data

Insufficient data

Transition from theoretical feasibility to clinical application

OSAS117128

Low intropetative bleeding and tracheotomy, decreased postoperative pain, hospital stay as well as incidence of dysphagia

Unstable cure rate varies from 45% to 90%, significant postoperative lingual oedema and transient hypogeusia

Combination of robotic resection of BOT and conventional surgery like uvulopalatopharyngoplasty or sphincter pharyngoplasty

Others

   

 Laryngeal clefts129

In common; minimal damage to surrounding normal tissues as well as speech and swallow function; excellent aesthetics

Laryngeal lefts: unsatisfactory cure rate

Laryngeal lefts: application of specific miniaturized instruments to obtain enough surgical space

 Laryngocele130

Laryngocele: short operative time

  

 Ectopic lingual thyroid131133

Ectopic lingual thyroid: short operative time and low recurrence

  

 Ptyalolithiasis134135

Ptyalolithiasis: high cure rate and low lingual nerve damage rate

  

 Vascular lesion136

   
  1. OSAS, obstructive sleep apnea syndrome.